Clinical and pharmacological studies with 5-hydroxy-2-formylpyridine thiosemicarbazone. 1972

R C DeConti, and B R Toftness, and K C Agrawal, and R Tomchick, and J A Mead, and J R Bertino, and A C Sartorelli, and W A Creasey

UI MeSH Term Description Entries
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D007948 Leukemia, Monocytic, Acute An acute myeloid leukemia in which 80% or more of the leukemic cells are of monocytic lineage including monoblasts, promonocytes, and MONOCYTES. Leukemia, Monoblastic, Acute,Leukemia, Myeloid, Acute, M5,Leukemia, Myeloid, Schilling-Type,Monoblastic Leukemia, Acute,Monocytic Leukemia, Acute,Myeloid Leukemia, Acute, M5,Myeloid Leukemia, Schilling-Type,Leukemia, Acute Monocytic,Leukemia, Myeloid, Schilling Type,Acute Monoblastic Leukemia,Acute Monoblastic Leukemias,Acute Monocytic Leukemia,Acute Monocytic Leukemias,Leukemia, Schilling-Type Myeloid,Leukemias, Acute Monoblastic,Leukemias, Acute Monocytic,Monoblastic Leukemias, Acute,Monocytic Leukemias, Acute,Myeloid Leukemia, Schilling Type,Schilling-Type Myeloid Leukemia
D007951 Leukemia, Myeloid Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites. Granulocytic Leukemia,Leukemia, Granulocytic,Leukemia, Myelocytic,Leukemia, Myelogenous,Myelocytic Leukemia,Myelogenous Leukemia,Myeloid Leukemia,Leukemia, Monocytic, Chronic,Monocytic Leukemia, Chronic,Chronic Monocytic Leukemia,Chronic Monocytic Leukemias,Granulocytic Leukemias,Leukemia, Chronic Monocytic,Leukemias, Chronic Monocytic,Leukemias, Granulocytic,Leukemias, Myelocytic,Leukemias, Myelogenous,Leukemias, Myeloid,Monocytic Leukemias, Chronic,Myelocytic Leukemias,Myelogenous Leukemias,Myeloid Leukemias
D007962 Leukocytes White blood cells. These include granular leukocytes (BASOPHILS; EOSINOPHILS; and NEUTROPHILS) as well as non-granular leukocytes (LYMPHOCYTES and MONOCYTES). Blood Cells, White,Blood Corpuscles, White,White Blood Cells,White Blood Corpuscles,Blood Cell, White,Blood Corpuscle, White,Corpuscle, White Blood,Corpuscles, White Blood,Leukocyte,White Blood Cell,White Blood Corpuscle
D008297 Male Males
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D002247 Carbon Isotopes Stable carbon atoms that have the same atomic number as the element carbon but differ in atomic weight. C-13 is a stable carbon isotope. Carbon Isotope,Isotope, Carbon,Isotopes, Carbon
D002850 Chromatography, Gel Chromatography on non-ionic gels without regard to the mechanism of solute discrimination. Chromatography, Exclusion,Chromatography, Gel Permeation,Chromatography, Molecular Sieve,Gel Filtration,Gel Filtration Chromatography,Chromatography, Size Exclusion,Exclusion Chromatography,Gel Chromatography,Gel Permeation Chromatography,Molecular Sieve Chromatography,Chromatography, Gel Filtration,Exclusion Chromatography, Size,Filtration Chromatography, Gel,Filtration, Gel,Sieve Chromatography, Molecular,Size Exclusion Chromatography
D002855 Chromatography, Thin Layer Chromatography on thin layers of adsorbents rather than in columns. The adsorbent can be alumina, silica gel, silicates, charcoals, or cellulose. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Chromatography, Thin-Layer,Thin Layer Chromatography,Chromatographies, Thin Layer,Chromatographies, Thin-Layer,Thin Layer Chromatographies,Thin-Layer Chromatographies,Thin-Layer Chromatography
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic

Related Publications

R C DeConti, and B R Toftness, and K C Agrawal, and R Tomchick, and J A Mead, and J R Bertino, and A C Sartorelli, and W A Creasey
December 1968, Cancer research,
R C DeConti, and B R Toftness, and K C Agrawal, and R Tomchick, and J A Mead, and J R Bertino, and A C Sartorelli, and W A Creasey
September 1974, Biochemical pharmacology,
R C DeConti, and B R Toftness, and K C Agrawal, and R Tomchick, and J A Mead, and J R Bertino, and A C Sartorelli, and W A Creasey
April 1979, European journal of cancer,
R C DeConti, and B R Toftness, and K C Agrawal, and R Tomchick, and J A Mead, and J R Bertino, and A C Sartorelli, and W A Creasey
June 1972, Journal of medicinal chemistry,
R C DeConti, and B R Toftness, and K C Agrawal, and R Tomchick, and J A Mead, and J R Bertino, and A C Sartorelli, and W A Creasey
January 2009, Bioinorganic chemistry and applications,
R C DeConti, and B R Toftness, and K C Agrawal, and R Tomchick, and J A Mead, and J R Bertino, and A C Sartorelli, and W A Creasey
January 1977, Molecular pharmacology,
R C DeConti, and B R Toftness, and K C Agrawal, and R Tomchick, and J A Mead, and J R Bertino, and A C Sartorelli, and W A Creasey
May 1963, Cancer research,
R C DeConti, and B R Toftness, and K C Agrawal, and R Tomchick, and J A Mead, and J R Bertino, and A C Sartorelli, and W A Creasey
March 1963, Cancer research,
R C DeConti, and B R Toftness, and K C Agrawal, and R Tomchick, and J A Mead, and J R Bertino, and A C Sartorelli, and W A Creasey
July 1975, The Biochemical journal,
R C DeConti, and B R Toftness, and K C Agrawal, and R Tomchick, and J A Mead, and J R Bertino, and A C Sartorelli, and W A Creasey
February 2015, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy,
Copied contents to your clipboard!